BackInnovAge Holding Overview

InnovAge Holding Current Cash

InnovAge Holding's current cash is $96M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$95.55M
↑ 58.05% YoYΔ $35.09M vs prior year quarter

Peer average

Loading

InnovAge Holding Current Cash History

Loading

InnovAge Holding vs. peers: Current Cash Comparison

Loading

InnovAge Holding Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

InnovAge Holding (INNV) FAQ

InnovAge Holding (INNV) currently reports a current cash of $96M as of March 2026. That compares with $60M in the prior-year period — up 58.0% year over year. Use the charts on this page to explore InnovAge Holding's current cash history and peer comparisons.

InnovAge Holding's current cash increased from $60M to $96M — a 58.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

InnovAge Holding reported $96M in current cash as of March 2026. That compares with $60M in the prior-year period — up 58.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $96M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for InnovAge Holding, and consider following INNV for alerts when major investors trade the stock.

InnovAge Holding is classified in the Healthcare sector. On current cash, it currently shows $96M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INNV with unrelated industries.